Phase 3 Hypogonadism Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 3
52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism
Hypogonadism, Male
Halozyme Therapeutics100 enrolled20 locationsNCT06689085
Recruiting
Phase 3
Impact of Peri-operative tEstosterone Levels on oNcological and Functional Outcomes in RadiCal prostatEctomy
Prostatic NeoplasmsHypogonadismTestosterone Deficiency
Canisius-Wilhelmina Hospital140 enrolled10 locationsNCT04833426
Terminated
Phase 2Phase 3
Biological actions of estradiol in men trial
Prostate CancerHypogonadism
University of Melbourne130 enrolled1 locationACTRN12614000689673
Completed
Phase 3Phase 4
Pharmacokinetics of Subcutaneous Injection (SC) of Testosterone in an Oil Vehicle: Nandrolone (ND) in Healthy Volunteers
Male Hypogonadism
Sydney Local Health District12 enrolled1 locationACTRN12613000068763
Withdrawn
Phase 3
The effect of non-steroidal anti-inflammatory drugs on hormones and metabolism in overweight men with low testosterone and obstructive sleep apnea (optional partner participation)
Hypogonadism- low testosteroneObstructive Sleep Apnea
Woolcock20 enrolled1 locationACTRN12612000536864